Inhibikase Therapeutics, Inc.
IKT· Nasdaq
Inhibikase Therapeutics, Inc.
- Last sale
- Oct 2, 2026 · +3.35%
- Market cap
- $279.77M
- 139.54M shares
- Filings
- 365
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2024 | 2024-12-31 | $0 | reported | |
| FY 2023 | 2023-12-31 | $260,501 | reported | |
| FY 2022 | 2022-12-31 | $123,440 | reported | |
| FY 2021 | 2021-12-31 | $3,100,605 | reported | |
| FY 2020 | 2020-12-31 | $698,468 | reported |
Inhibikase Therapeutics, Inc. · CIK 1750149 · Engraved from SEC EDGAR
